Clinical Trials Browser

Interventional × Head and Neck Carcinoma × Head & Neck × Clear all

NCT05115825 2026-02-27

Pain Management for Head and Neck Cancer Survivors

Phase NA Completed

Head and Neck Carcinoma

NCT04890834 2026-02-19

Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

Phase NA Active not recruiting

Head and Neck Carcinoma

NCT07227792 2025-12-17

Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer

Phase NA Recruiting

Head and Neck Carcinoma

NCT06985784 2025-11-10

Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers

Phase NA Recruiting

Head and Neck Carcinoma

NCT06896695 2025-10-31

A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial

Phase NA Recruiting

Head and Neck Carcinoma

NCT02615275 2025-10-27

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Phase NA Active not recruiting

Head and Neck Carcinoma

NCT05077072 2025-10-20

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Phase 2 Active not recruiting

Head and Neck Carcinoma

NCT02543320 2025-10-14

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

Phase NA Active not recruiting

Head and Neck Carcinoma

NCT05828004 2025-08-28

The SHINE-MDT Randomized Controlled Trial

Phase NA Completed

Head and Neck Carcinoma

NCT03489252 2025-08-22

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Phase NA Completed

Head and Neck Carcinoma

NCT02718820 2024-01-09

Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer

Phase 1/2 Completed

22 enrolled 10 charts

Head and Neck Carcinoma

NCT03745690 2022-03-17

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Phase 1/2 Withdrawn

Head and Neck Carcinoma

NCT03261180 2020-02-25

Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer

Phase NA Withdrawn

Head and Neck Carcinoma